Drug Profile
NipentExtra
Alternative Names: PentoExtra; Pentostatin - SuperGenLatest Information Update: 16 Nov 2006
Price :
$50
*
At a glance
- Originator SuperGen
- Class
- Mechanism of Action Adenosine deaminase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hairy cell leukaemia
Most Recent Events
- 25 Jan 1999 PentoExtra is now called NipentExtra
- 08 May 1998 Preclinical development for Hairy cell leukaemia in USA (Unknown route)